News and Views
Recent Price Movement and Market Context
Fredun Pharmaceuticals has demonstrated notable resilience and strength in its stock performance. Over the past week, the stock gained 2.53%, contrasting with the Sensex’s decline of 1.86% during the same period. Despite a slight dip of 2.05% over the last month, the stock’s year-to-date performance remains marginally better than the benchmark, with a decline of 1.86% compared to the Sensex’s 2.16% fall. Most impressively, the company has delivered a remarkable 132.08% return over the last year, vastly outperforming the Sensex’s 9.00% gain. This exceptional growth trajectory highlights the stock’s strong momentum and investor appeal.
On 14-Jan, the stock opened with a gap up of 2.12%, signalling positive sentiment from the outse...
Read full news article
